ClinicalTrials.Veeva

Menu

Sugar Sweetened Beverages (SSB)- Effects on Metabolism

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Metabolism

Treatments

Procedure: Soft drink consumption

Study type

Interventional

Funder types

Other

Identifiers

NCT01733563
SSB-Effects on metabolism

Details and patient eligibility

About

The objective of this study is to investigate the impact of sugar sweetened beverages on the fat metabolism of healthy young men. It is well known that consumption of beverages sweetened with fructose is associated with different health risks such as type 2 diabetes. The present study has been designed to dissect differences in the metabolic pathways of fructose and glucose, but also metabolic adaptations during fructose, glucose and sucrose diets. During a period of seven weeks subjects will consume either fructose, glucose or sucrose sweetened beverages or continue their usual drinking habits. During these seven weeks there will be different metabolic investigations using stable isotope tracers. First, the rate of lipolysis and beta-oxidation will be determined. Second, the rates of fatty acid synthesis will be measured. During all examinations there will also be substrate- and energy-utilization measurements by indirect calorimetry, blood analysis and morphometric measurements. Based on the literature main hypotheses are: Fructose enhances de novo lipogenesis postprandially and also in the fasting state significantly more than glucose by enhanced expression of lipogenic enzymes. Fructose decreases beta oxidation via downregulation of oxidative enzymes.

Enrollment

96 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy male volunteers aged 18-30
  • BMI between 19-24 kg/m2
  • Non-smoker

Exclusion criteria

  • Acute or chronic infections, malignant disease, renal, hepatic (more than two-fold increased transaminases), pulmonary, neurological (epilepsy) or psychiatric diseases, manifested atherosclerosis, or any other disease precluding participation in the study.
  • Diabetes
  • Known alcohol, substance or drug abuse, concomitant medication
  • More than three hours of physical exercise per week
  • Consumption of more than 2 times 3 dl SSB daily
  • Subjects likely to fail to comply with the study protocol
  • Subjects who do not give informed consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

96 participants in 4 patient groups

fructose sweetened beverage
Experimental group
Description:
Soft drink consumption: Subjects have to drink a fructose sweetened beverage (3x 200ml per day, 13.3g fructose/100ml) during 7 weeks
Treatment:
Procedure: Soft drink consumption
glucose sweetened beverage
Experimental group
Description:
Soft drink consumption: Subjects have to drink a glucose sweetened beverage (3x 200ml per day, 13.3g glucose/100ml) during 7 weeks
Treatment:
Procedure: Soft drink consumption
sucrose sweetened beverage
Experimental group
Description:
Soft drink consumption: Subjects have to drink a sucrose sweetened beverage (3x 200ml per day, 13.3g sucrose/100ml) during 7 weeks
Treatment:
Procedure: Soft drink consumption
No change of eating habits
Experimental group
Description:
No Soft drink consumption (no soft drink diet): Subjects do not change their eating habits during 7 weeks
Treatment:
Procedure: Soft drink consumption

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems